Literature DB >> 29697017

High-fat diet induces depression-like behaviour in mice associated with changes in microbiome, neuropeptide Y, and brain metabolome.

Ahmed M Hassan1, Giulia Mancano2, Karl Kashofer3, Esther E Fröhlich1, Andrija Matak3, Raphaela Mayerhofer1, Florian Reichmann1, Marta Olivares4, Audrey M Neyrinck4, Nathalie M Delzenne4, Sandrine P Claus2, Peter Holzer1,5.   

Abstract

Objectives: The biological mechanisms linking diet-related obesity and depression remain unclear. Therefore, we examined the impact of high-fat diet (HFD) on murine behaviour, intestinal microbiome, brain metabolome, neuropeptide Y (NPY) expression, and dipeptidyl peptidase-4 (DPP-4) activity.
Methods: Male C57Bl/6J mice were fed an HFD (60 kJ% from fat) or control diet (12 kJ% from fat) for 8 weeks, followed by behavioural phenotyping. Caecal microbiome was analysed by 16S rDNA sequencing, brain metabolome by 1H nuclear magnetic resonance, NPY expression by PCR and immunoassay, and dipeptidyl peptidase-4 (DPP-4) activity by enzymatic assay. The effect of a 4-week treatment with imipramine (7 mg/kg/day) and the DPP-4 inhibitor sitagliptin (50 mg/kg/day) on HFD-induced behavioural changes was also tested.
Results: HFD led to a depression-like phenotype as revealed by reduced sociability and sucrose preference. In the caecum, HFD diminished the relative abundance of Bacteroidetes and increased the relative abundance of Firmicutes and Cyanobacteria. In the brain, HFD modified the metabolome of prefrontal cortex and striatum, changing the relative concentrations of molecules involved in energy metabolism (e.g. lactate) and neuronal signalling (e.g. γ-aminobutyric acid). The expression of NPY in hypothalamus and hippocampus was decreased by HFD, whereas plasma NPY and DPP-4-like activity were increased. The HFD-induced anhedonia remained unaltered by imipramine and sitagliptin.Discussion: The depression-like behaviour induced by prolonged HFD in mice is associated with distinct alterations of intestinal microbiome, brain metabolome, NPY system, and DPP-4-like activity. Importantly, the HFD-evoked behavioural disturbance remains unaltered by DPP-4 inhibition and antidepressant treatment with imipramine.

Entities:  

Keywords:  Depression; Dipeptidyl peptidase-4; High-fat diet; Metabolome; Microbiome; Neuropeptide Y; Obesity; γ-Aminobutyric acid

Mesh:

Substances:

Year:  2018        PMID: 29697017     DOI: 10.1080/1028415X.2018.1465713

Source DB:  PubMed          Journal:  Nutr Neurosci        ISSN: 1028-415X            Impact factor:   4.994


  49 in total

1.  Opioid System Contributes to the Trifluoromethyl-Substituted Diselenide Effectiveness in a Lifestyle-Induced Depression Mouse Model.

Authors:  Sabrina Grendene Müller; Natália Silva Jardim; Milene Arrial Trindade; Cristina Wayne Nogueira
Journal:  Mol Neurobiol       Date:  2021-01-08       Impact factor: 5.590

2.  Reshaping circadian metabolism in the suprachiasmatic nucleus and prefrontal cortex by nutritional challenge.

Authors:  Paola Tognini; Muntaha Samad; Kenichiro Kinouchi; Yu Liu; Jean-Christophe Helbling; Marie-Pierre Moisan; Kristin L Eckel-Mahan; Pierre Baldi; Paolo Sassone-Corsi
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-10       Impact factor: 11.205

3.  Reversal of a Treatment-Resistant, Depression-Related Brain State with the Kv7 Channel Opener Retigabine.

Authors:  Mengyang Feng; Nicole A Crowley; Akshilkumar Patel; Yao Guo; Sierra E Bugni; Bernhard Luscher
Journal:  Neuroscience       Date:  2019-03-08       Impact factor: 3.590

4.  Metformin Promotes Anxiolytic and Antidepressant-Like Responses in Insulin-Resistant Mice by Decreasing Circulating Branched-Chain Amino Acids.

Authors:  Juliane Zemdegs; Hugo Martin; Hiranya Pintana; Sebastien Bullich; Stella Manta; Marie A Marqués; Cédric Moro; Sophie Layé; Fabien Ducrocq; Nipon Chattipakorn; Siriporn C Chattipakorn; Claire Rampon; Luc Pénicaud; Xavier Fioramonti; Bruno P Guiard
Journal:  J Neurosci       Date:  2019-06-03       Impact factor: 6.167

Review 5.  Central and Peripheral Inflammation Link Metabolic Syndrome and Major Depressive Disorder.

Authors:  Kenny L Chan; Flurin Cathomas; Scott J Russo
Journal:  Physiology (Bethesda)       Date:  2019-03-01

Review 6.  Diet and the Microbiota-Gut-Brain Axis: Sowing the Seeds of Good Mental Health.

Authors:  Kirsten Berding; Klara Vlckova; Wolfgang Marx; Harriet Schellekens; Catherine Stanton; Gerard Clarke; Felice Jacka; Timothy G Dinan; John F Cryan
Journal:  Adv Nutr       Date:  2021-07-30       Impact factor: 8.701

7.  High-fat diet impairs duodenal barrier function and elicits glia-dependent changes along the gut-brain axis that are required for anxiogenic and depressive-like behaviors.

Authors:  Luisa Seguella; Mirella Pesce; Riccardo Capuano; Fabrizio Casano; Marcella Pesce; Chiara Corpetti; Martina Vincenzi; Daniela Maftei; Roberta Lattanzi; Alessandro Del Re; Giovanni Sarnelli; Brian D Gulbransen; Giuseppe Esposito
Journal:  J Neuroinflammation       Date:  2021-05-16       Impact factor: 8.322

Review 8.  Potential therapeutic applications of the gut microbiome in obesity: from brain function to body detoxification.

Authors:  Béatrice S-Y Choi; Laurence Daoust; Geneviève Pilon; André Marette; Angelo Tremblay
Journal:  Int J Obes (Lond)       Date:  2020-06-10       Impact factor: 5.095

9.  High Fructose Corn Syrup-Moderate Fat Diet Potentiates Anxio-Depressive Behavior and Alters Ventral Striatal Neuronal Signaling.

Authors:  Ayanabha Chakraborti; Christopher Graham; Sophie Chehade; Bijal Vashi; Alan Umfress; Pradeep Kurup; Benjamin Vickers; H Alexander Chen; Rahul Telange; Taylor Berryhill; William Van Der Pol; Mickie Powell; Stephen Barnes; Casey Morrow; Daniel L Smith; M Shahid Mukhtar; Stephen Watts; Gregory Kennedy; James Bibb
Journal:  Front Neurosci       Date:  2021-05-26       Impact factor: 4.677

10.  Small Intestinal Tuft Cell Activity Associates With Energy Metabolism in Diet-Induced Obesity.

Authors:  Pankaj Arora; Daniel Andersen; Janne Marie Moll; Niels Banhos Danneskiold-Samsøe; Liqin Xu; Biaofeng Zhou; Georgios Kladis; Philipp Rausch; Christopher T Workman; Karsten Kristiansen; Susanne Brix
Journal:  Front Immunol       Date:  2021-05-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.